Oblique
      News
      Oblique Therapeutics AB (publ.) is pleased to announce that the United States Patent and Trademark Office

      Please read our latest press release, clicking here:

      Abiprot-Oblique Therapeutics New Patent Granted US- Jan 2022

       

      Oblique Therapeutics AB (publ.) is pleased to announce that the United States Patent and Trademark Office has granted a patent for its innovative AbiProt® technology